G-CSF- and erythropoietin-based cell therapy: a promising strategy for angiomyogenesis in myocardial infarction.
about
G-CSF- and erythropoietin-based cell therapy: a promising strategy for angiomyogenesis in myocardial infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
G-CSF- and erythropoietin-base ...... esis in myocardial infarction.
@en
G-CSF- and erythropoietin-base ...... esis in myocardial infarction.
@nl
type
label
G-CSF- and erythropoietin-base ...... esis in myocardial infarction.
@en
G-CSF- and erythropoietin-base ...... esis in myocardial infarction.
@nl
prefLabel
G-CSF- and erythropoietin-base ...... esis in myocardial infarction.
@en
G-CSF- and erythropoietin-base ...... esis in myocardial infarction.
@nl
P2860
P356
P1476
G-CSF- and erythropoietin-base ...... esis in myocardial infarction.
@en
P2093
Hyo-Soo Kim
Hyun-Jae Kang
P2860
P304
P356
10.1586/14779072.6.5.703
P577
2008-06-01T00:00:00Z